Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1858 ARTÍCULOS , VIENDO DEL 406 AL 420

Modulation of MicroRNAs as a Potential Molecular Mechanism Involved in the Beneficial Actions of Physical Exercise in Alzheimer Disease

Improta-Caria AC, Nonaka CKV, Cavalcante BRR, De Sousa RAL, Aras Júnior R, Souza BSF.

Int J Mol Sci. 2020 Jul 14;21(14):4977. doi: 10.3390/ijms21144977.

Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease

Guo T, Zhang D, Zeng Y, Huang TY, Xu H, Zhao Y.

Mol Neurodegener. 2020 Jul 16;15(1):40. doi: 10.1186/s13024-020-00391-7.

Current Strategies and Novel Drug Approaches for Alzheimer Disease

Ghai R, Nagarajan K, Arora M, Grover P, Ali N, Kapoor G.

CNS Neurol Disord Drug Targets. 2020;19(9):676-690. doi: 10.2174/1871527319666200717091513.

Dietary Interventions to Prevent or Delay Alzheimer's Disease: What the Evidence Shows

Bartochowski Z, Conway J, Wallach Y, Chakkamparambil B, Alakkassery S, Grossberg GT.

Curr Nutr Rep. 2020 Sep;9(3):210-225. doi: 10.1007/s13668-020-00333-1.

Pathogenesis and promising therapeutics of Alzheimer disease through eIF2α pathway and correspondent kinases

Moradi Majd R, Mayeli M, Rahmani F.

Metab Brain Dis. 2020 Dec;35(8):1241-1250. doi: 10.1007/s11011-020-00600-8. Epub 2020 Jul 17.

Passive immunotherapies targeting Aβ and tau in Alzheimer's disease

Plotkin SS, Cashman NR.

Neurobiol Dis. 2020 Oct;144:105010. doi: 10.1016/j.nbd.2020.105010. Epub 2020 Jul 16.

From beta amyloid to altered proteostasis in Alzheimer's disease

Bruni AC, Bernardi L, Gabelli C.

Ageing Res Rev. 2020 Dec;64:101126. doi: 10.1016/j.arr.2020.101126. Epub 2020 Jul 16.

Should drug discovery scientists still embrace the amyloid hypothesis for Alzheimer's disease or should they be looking elsewhere?

Imbimbo BP, Ippati S, Watling M.

Expert Opin Drug Discov. 2020 Nov;15(11):1241-1251. doi: 10.1080/17460441.2020.1793755. Epub 2020 Jul 20.

Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials

Yu JT, Xu W, Tan CC, Andrieu S, Suckling J, Evangelou E, Pan A, Zhang C, Jia J, Feng L, Kua EH, Wang YJ, Wang HF, Tan MS, Li JQ, Hou XH, Wan Y, Tan L, Mok V, Tan L, Dong Q, Touchon J, Gauthier S, Aisen PS, Vellas B.

J Neurol Neurosurg Psychiatry. 2020 Nov;91(11):1201-1209. doi: 10.1136/jnnp-2019-321913. Epub 2020 Jul 20.

Brain cell somatic gene recombination and its phylogenetic foundations

Kaeser G, Chun J.

J Biol Chem. 2020 Sep 4;295(36):12786-12795. doi: 10.1074/jbc.REV120.009192. Epub 2020 Jul 22.

Brain angiotensin II and angiotensin IV receptors as potential Alzheimer's disease therapeutic targets

Royea J, Hamel E.

Geroscience. 2020 Oct;42(5):1237-1256. doi: 10.1007/s11357-020-00231-y. Epub 2020 Jul 22.

Genetic factors related to the immune system in subjects at risk of developing Alzheimer's disease

Prendecki M, Kowalska M, Łagan-Jędrzejczyk U, Piekut T, Krokos A, Kozubski W, Dorszewska J.

J Integr Neurosci. 2020 Jun 30;19(2):359-371. doi: 10.31083/j.jin.2020.02.110.

An evaluation on potential anti-inflammatory effects of β-lapachone

Mokarizadeh N, Karimi P, Kazemzadeh H, Fathi Maroufi N, Sadigh-Eteghad S, Nikanfar S, Rashtchizadeh N.

Int Immunopharmacol. 2020 Oct;87:106810. doi: 10.1016/j.intimp.2020.106810. Epub 2020 Jul 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias